about
Ankylosing spondylitis: A state of the art factual backboneSecukinumab for ankylosing spondylitis and psoriatic arthritisHLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps.Work outcome in yet undiagnosed patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis; results of a cross-sectional study among patients with chronic low back pain.Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis.Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE).Spondyloarthritis in a pediatric population: risk factors for sacroiliitis.External Validation of a Referral Rule for Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain.Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumabRelationship between optimism and quality of life in patients with two chronic rheumatic diseases: axial spondyloarthritis and chronic low back pain: a cross sectional study of 288 patients.The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis.Surgical Therapy of Cervical Spine Fracture in Patients With Ankylosing SpondylitisPrevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.Patients with ankylosing spondylitis have increased sick leave--a registry-based case-control study over 7 yrs.The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.Infliximab in the treatment of ankylosing spondylitis.Treatment of kyphosis in ankylosing spondylitis by osteotomy through the gap of a pathological fracture: a retrospective study.Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil.Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients.Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis.Incidental Finding of Cor Triatriatum Sinister in an Asymptomatic Woman With Ankylosing SpondylitisEffect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.Comorbidity, disability, and healthcare expenditure of ankylosing spondylitis in Korea: A population-based study.Relationship between diet and ankylosing spondylitis: A systematic review.Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study.Trends in the prevalence and incidence of ankylosing spondylitis in South Korea, 2010-2015 and estimated differences according to income status.Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases
P2860
Q26782184-AC6ED688-2AA2-49A0-9ED0-E2AA87D049C7Q28071474-F0B6D997-AEA4-48F5-AA66-F2842C522FF9Q32173857-989EBBC1-D7F1-46C4-A653-F45BCE8EACF7Q33808563-3007C48D-EFBE-4FB1-A770-AD4579C8F44CQ33923298-44CCF0F7-3318-45C3-8A7C-59624BCE68C2Q34758808-6E6571D3-3453-4C20-8A32-41842E7E0D74Q34976782-AF6763BA-7232-4349-BCD7-87C68B5FBF83Q35705614-DE70065A-E7A1-4D2D-8ADC-CE58BFF720CDQ35759171-BCB4C748-3AE5-4A8D-A457-F9D9A25624CDQ35819270-72B75C57-DCB2-400D-AF4D-086F6936CC7AQ35953515-D03E69D6-4A18-4E80-B76D-846BA19A4040Q36366162-20E70811-07D8-46A8-A9D5-FB4469769A34Q36930716-52D92DBA-DE4C-407F-8E14-75855CB8878EQ37026085-C00497D2-2D97-4EC3-82B6-6F5275F1864AQ37092635-A45366F3-F710-48EA-8209-06A49D7113E3Q37100632-BA6BD158-1EB2-40A8-8209-2FABEF6FABBEQ37172521-9678B471-26EB-46E7-A746-4AAA80668096Q37172795-1E6A08F4-8197-47FE-A885-C1E87DE09B2DQ37290474-8693F303-60F8-4426-B4DD-930FEE195AD9Q37402815-55A5EC88-015B-48F9-82DF-59DD444D0215Q37453002-A589A026-A78E-4D8C-9109-8524A9B6779DQ37465518-6451C90E-DE36-4BBE-BFFB-4BB46CFA84B5Q38672570-9E3B11A1-C817-4D62-81F6-B4AE03262DD7Q40948411-F2366E5E-00A4-476D-BD22-C937A554E32AQ41875264-0AD7A2EC-2221-4735-AC86-5BB38A868065Q42137245-890B0B52-6546-469B-B052-F94A1AA301D6Q45893661-9AA28359-9962-4D83-A7F6-369BC791A6E3Q47260079-EC35B4D3-6CCC-465A-879D-E43C791D3F6CQ50114438-B40C61A7-8D85-4210-9038-787DF2552298Q53279948-57C2C08E-6D69-4AB4-B15E-B755FD3FF622Q53829185-C8FDDCD2-E1B8-4E34-BEED-A7DE06DA4A67Q54963738-A81289D5-CB7F-4D28-A14D-29DD27E91AE8Q58558578-7C24571B-BDA9-4ECA-9FC4-EA1E7E35C143
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The burden of ankylosing spondylitis.
@ast
The burden of ankylosing spondylitis.
@en
type
label
The burden of ankylosing spondylitis.
@ast
The burden of ankylosing spondylitis.
@en
prefLabel
The burden of ankylosing spondylitis.
@ast
The burden of ankylosing spondylitis.
@en
P1476
The burden of ankylosing spondylitis
@en
P2093
Annelies Boonen
Sjef M van der Linden
P577
2006-09-01T00:00:00Z